Log in

OTCMKTS:EXETFExtendicare Stock Price, Forecast & News

$4.10
-0.01 (-0.21 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.08
Now: $4.10
$4.13
50-Day Range
$4.00
MA: $4.26
$4.78
52-Week Range
$3.45
Now: $4.10
$7.26
Volume955 shs
Average Volume6,350 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Extendicare, Inc. operates as a holding company that engages in the provision of nursing care, home health care, retirement living, and management and consulting services. It operates through the following business segments: Long-Term Care, Retirement Living, Home Health Care, and Other Canadian Operations. The Long-Term Care segment represents long-term care centres the company owns and operates in the country. The Retirement Living segment includes acquired retirement communities, and newly constructed and opened communities. The Other Canadian operations segment is composed of its management, consulting and group purchasing operations. The company was founded by Harold Livergant and John MacKay on August 7, 1968 and is headquartered in Markham, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.04 out of 5 stars


Industry, Sector and Symbol

Industry Hospital/Nursing Management
Sub-IndustryN/A
Current SymbolOTCMKTS:EXETF
CUSIPN/A
CIKN/A
WebN/A
Phone(905) 470-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive EXETF News and Ratings via Email

Sign-up to receive the latest news and ratings for EXETF and its competitors with MarketBeat's FREE daily newsletter.

Extendicare (OTCMKTS:EXETF) Frequently Asked Questions

How has Extendicare's stock been impacted by COVID-19 (Coronavirus)?

Extendicare's stock was trading at $4.90 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EXETF stock has decreased by 16.3% and is now trading at $4.1015. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Extendicare?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Extendicare.

How often does Extendicare pay dividends? What is the dividend yield for Extendicare?

Extendicare announced a monthly dividend on Thursday, February 20th. Shareholders of record on Friday, February 28th will be given a dividend of $0.0302 per share on Monday, March 16th. This represents a $0.36 annualized dividend and a yield of 8.84%. The ex-dividend date of this dividend is Thursday, February 27th. View Extendicare's dividend history.

What price target have analysts set for EXETF?

3 brokerages have issued 1-year price objectives for Extendicare's stock. Their forecasts range from $6.50 to $7.50. On average, they expect Extendicare's share price to reach $7.00 in the next year. This suggests a possible upside of 70.7% from the stock's current price. View analysts' price targets for Extendicare.

Has Extendicare been receiving favorable news coverage?

News coverage about EXETF stock has been trending negative this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Extendicare earned a news impact score of -2.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Extendicare.

Who are Extendicare's key executives?

Extendicare's management team includes the following people:
  • Michael R. Guerriere, President, Chief Executive Officer & Director
  • David E. Bacon, Chief Financial Officer & Senior Vice President
  • Brandon Parent, Secretary, Vice President & General Counsel
  • Elaine E. Everson, Vice President-Corporate Development
  • Jillian Elizabeth Fountain, Vice President-Investor Relations

What is Extendicare's stock symbol?

Extendicare trades on the OTCMKTS under the ticker symbol "EXETF."

How do I buy shares of Extendicare?

Shares of EXETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Extendicare's stock price today?

One share of EXETF stock can currently be purchased for approximately $4.10.

How can I contact Extendicare?

The company can be reached via phone at (905) 470-4000.

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.